Wall Street Zen cuts Molina Healthcare stock to Sell
Published on 10/06/2026 at 11:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Molina Healthcare (ISIN US60855R1005) stock was trading at EUR 174.10 at Lang & Schwarz on October 6, 2026 at 11:37 a.m. CEST, up 1.52 percent versus the prior close of EUR 171.50. On October 4, 2026, Wall Street Zen downgraded the stock from Hold to Sell, according to MarketBeat.
Q2 earnings beat consensus
Molina reported adjusted earnings per share of USD 1.51 for the second quarter of 2026, exceeding the USD 1.39 consensus by USD 0.12, while revenue reached USD 10.87 billion and fell 4.80 percent year over year, MarketBeat reported. The combination matters because the earnings beat did not erase the revenue contraction that is shaping the current analyst debate.
The same quarter produced USD 1.19 in GAAP diluted earnings per share and USD 60.0 million in net income attributable to common shareholders. Premium revenue stood at USD 10.2 billion, according to the Q2 2026 earnings call transcript published by Fortune.
Guidance improves but risks remain
Management raised full-year 2026 adjusted earnings guidance by USD 0.25 to at least USD 5.25 per share, while keeping premium revenue guidance at USD 42.0 billion, according to Fortune. The guidance also showed an uneven business mix: Medicare improved by USD 1.50 per share, while Marketplace guidance declined by USD 1.50 per share to a USD 0.75 loss.
That split helps explain the cautious rating. Molina expects a 92.6 percent consolidated medical cost ratio for 2026, with Medicaid at 92.9 percent and Marketplace at 90.0 percent, leaving medical-cost execution as a central earnings variable.
Next results arrive October 21
Molina is scheduled to release third-quarter 2026 results after the market closes on October 21, 2026, with the date also listed by Yahoo Finance. Analysts tracked by MarketBeat hold an average rating of Hold and an average price target of USD 202.44, while the stock's 52-week range is USD 121.06 to USD 244.89 as of October 5, 2026.
Stock trades above prior close
Molina Healthcare stock was trading at EUR 174.10 at Lang & Schwarz on October 6, 2026 at 11:37 a.m. CEST, up 1.52 percent versus the Lang & Schwarz prior close of EUR 171.50 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Molina Healthcare stock.
Molina Healthcare stock facts
- Company: Molina Healthcare, Inc.
- ISIN: US60855R1005
- Ticker: MOH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 6, 2026, 11:37 a.m. CEST): EUR 174.10
- Change versus prior close: plus 1.52 percent
- Prior close Lang & Schwarz (October 5, 2026): EUR 171.50
- Market capitalization: USD 10.1 billion (as of October 5, 2026)
- 52-week range: USD 121.06-244.89 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Next earnings date: October 21, 2026
